Amlodipine/atorvastatin

Amlodipine/atorvastatin
Combination of
AmlodipineCalcium channel blocker
AtorvastatinStatin
Clinical data
Trade namesCaduet, Envacar, others
AHFS/Drugs.comProfessional Drug Facts
License data
Pregnancy
category
  • AU: D
  • Contraindicated
Routes of
administration		By mouth
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • US: ℞-only
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
KEGG
CompTox Dashboard (EPA)
  (verify)

Amlodipine/atorvastatin, sold under the brand name Caduet among others, is a fixed-dose combination medication for the treatment of high cholesterol and high blood pressure. It contains a statin and a calcium channel blocker.[1][2]

Society and culture

Brand names

Amlodipine/atorvastatin is marketed under the brand name Caduet in the United States, Australia, and Russia, and Envacar in the Philippines.[3][4]

In some countries Caduet is marketed by Viatris after Upjohn was spun off from Pfizer.[5][6][7]

References

  1. ^ Curran MP (2010). "Amlodipine/Atorvastatin". Drugs. 70 (2). Springer Science+Business Media: 191–213. doi:10.2165/11204420-000000000-00000. ISSN 0012-6667. PMID 20108992. S2CID 209144335.
  2. ^ Devabhaktuni M, Bangalore S (2009). "Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives". Vascular Health and Risk Management. 5 (1): 377–87. doi:10.2147/vhrm.s3339. PMC 2686256. PMID 19475775.
  3. ^ "Caduet - Drugs.com". Archived from the original on 19 June 2014.
  4. ^ "Envacar - Drugs.com". Archived from the original on 20 June 2014.
  5. ^ "Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan". Pfizer. 16 November 2020. Retrieved 17 June 2024 – via Business Wire.
  6. ^ "Caduet". Pfizer. Retrieved 17 June 2024.
  7. ^ "Brands". Viatris. 16 November 2020. Retrieved 17 June 2024.


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.